These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 37354145)

  • 1. Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF.
    Bozkurt B; Savarese G; Adamsson Eryd S; Bodegård J; Cleland JGF; Khordoc C; Kishi T; Thuresson M; Vardeny O; Zhang R; Lund LH
    JACC Heart Fail; 2023 Oct; 11(10):1320-1332. PubMed ID: 37354145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF).
    Savarese G; Kishi T; Vardeny O; Adamsson Eryd S; Bodegård J; Lund LH; Thuresson M; Bozkurt B
    JACC Heart Fail; 2023 Jan; 11(1):1-14. PubMed ID: 36202739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
    Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
    Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction.
    Sandhu AT; Kohsaka S; Turakhia MP; Lewis EF; Heidenreich PA
    JAMA Cardiol; 2022 Feb; 7(2):130-139. PubMed ID: 34757380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Guideline-Directed Medical Therapy in Heart Failure Patients With and Without Chronic Kidney Disease: A Meta-Analysis of 63,677 Patients.
    Clark KM; Mahboob F; Evans J; Sun JH; Wang N
    Heart Lung Circ; 2024 Mar; 33(3):281-291. PubMed ID: 38365495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Guideline-Directed Medical Therapy During Hospitalization Improves Prognosis in Patients With Worsening Heart Failure Requiring Readmissions.
    Matsukawa R; Kabu K; Koga E; Hara A; Kisanuki H; Sada M; Okabe K; Okahara A; Tokutome M; Kawai S; Ogawa K; Matsuura H; Mukai Y
    Circ J; 2024 Aug; 88(9):1416-1424. PubMed ID: 39034132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization.
    Bhagat AA; Greene SJ; Vaduganathan M; Fonarow GC; Butler J
    JACC Heart Fail; 2019 Jan; 7(1):1-12. PubMed ID: 30414818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany.
    Michel A; Lecomte C; Ohlmeier C; Raad H; Basedow F; Haeckl D; Beier D; Evers T
    Am J Cardiovasc Drugs; 2024 May; 24(3):409-418. PubMed ID: 38573461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure.
    Vaduganathan M; Greene SJ; Zhang S; Solomon N; Chiswell K; Devore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; Mcdermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Fonarow GC
    J Card Fail; 2022 Apr; 28(4):554-563. PubMed ID: 34785402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry.
    Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G
    Eur J Heart Fail; 2023 Jul; 25(7):1132-1144. PubMed ID: 37317585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
    Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
    ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States.
    Yan BW; Spahillari A; Pandya A
    Circ Cardiovasc Qual Outcomes; 2023 Jun; 16(6):e009793. PubMed ID: 37278232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy.
    Malgie J; Clephas PRD; Brunner-La Rocca HP; de Boer RA; Brugts JJ
    Heart Fail Rev; 2023 Sep; 28(5):1221-1234. PubMed ID: 37311917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System Inhibitors.
    Pierce JB; Blumer V; Choi S; Hardy NC; Greiner MA; Carnicelli AP; Shen X; Lippmann SJ; Peterson PN; Allen LA; Fonarow GC; Mentz RJ; Greene SJ; O'Brien EC
    Am J Cardiol; 2023 Oct; 204():151-158. PubMed ID: 37544137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure.
    Greene SJ; Ayodele I; Pierce JB; Khan MS; Lewsey SC; Yancy CW; Alhanti B; Van Spall HGC; Allen LA; Fonarow GC
    JACC Heart Fail; 2024 Aug; 12(8):1365-1377. PubMed ID: 38597866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study.
    Quiroga B; Ortiz A; Núñez S; Kislikova M; González Sanchidrián S; Broseta JJ; Albines ZS; Escamilla Cabrera B; Rivero Viera Y; Rodriguez Santarelli D; Salanova Villanueva L; Lopez Rodriguez F; Cancho Castellano B; Ibáñez Cerezon M; Gutierrez Rivas CP; Aresté N; Campos Gutiérrez B; Ródenas Gálvez A; Glucksmann Pizá MC; Balda Manzanos S; Soldevila A; Rodríguez Gayo L; Moral Berrio E; Ortega Diaz M; Beltrán Catalán S; Puente García A; Ángel Rojas M; Sosa Barrios RH; Santana Zapatero H; Rangel Hidalgo G; Martinez Canet AM; Díez J;
    Cardiorenal Med; 2024; 14(1):202-214. PubMed ID: 38513622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
    Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J
    JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Navigating Heart Failure: Unveiling Sex Disparities in Guideline-Directed Medical Therapy Combinations.
    Celik A; Sahin A; Ata N; Colluoglu IT; Ural D; Kanik EA; Ayvali MO; Ulgu MM; Birinci S; Yilmaz MB
    Am J Cardiol; 2024 Apr; 216():27-34. PubMed ID: 38266795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.